September is always a busy time for conferences. This month Cyprotex presented at the BMSS meeting in Manchester, the EUROTOX congress in Bratislava, the DMG meeting in London, the SPS meeting in Berlin and the North American ISSX meeting in Rhode Island. You can access the posters and presentations from these events below.
Earlier this month, Dr Mohammed Atari, Senior Mathematical Modeller at Cyprotex, attended the prestigious IPEM awards ceremony in London to receive the Innovation Early Career award. This award was presented in recognition of Mohammed's contribution to scientific modelling through the development of novel models to predict pharmaceutical properties.
We would also like to announce some exciting news from our parent company, Evotec. In August, Evotec completed the acquisition of Aptuit. The acquisition not only increases capabilities within integrated drug discovery projects, but greatly expands service offering within preclinical development, enhancing our IND-enabling and integrated CMC expertise. Learn more about the Aptuit acquisition and further updates from Evotec below.